Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)

NCT01433731

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford University Stanford, California, United States
  • Northwestern University Dept of Dermatology Chicago, Illinois, United States
  • University Hospitals Case Medical Center Cleveland, Ohio, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

NCT01403636

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Investigational Site Number 840012 Los Angeles, California, United States
  • Investigational Site Number 840104 Fort Meyers, Florida, United States
  • Investigational Site Number 840006 Augusta, Georgia, United States
  • Investigational Site Number 840011 Maywood, Illinois, United States
View all 30 locations
View Trial Details
Completed

A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma

NCT00322985

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Cancer Care Manitoba Winnipeg, Manitoba, Canada
  • Queen Elizabeth II, Health Services Centre Halifax, Nova Scotia, Canada
View Trial Details

Related conditions